Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Alzheimer Disease Progression
NCT00982202Phase 2Completed
- Sponsor
- National Institute on Aging
- Start
- Jan 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in Alzheimer's disease (AD), sponsored by National Institute on Aging. Started Jan 2002; status: completed.
02
Drugs
pioglitazone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00982202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982202.